1 | 1 | | |
---|
2 | 2 | | |
---|
3 | 3 | | Req. No. 10084 Page 1 1 |
---|
4 | 4 | | 2 |
---|
5 | 5 | | 3 |
---|
6 | 6 | | 4 |
---|
7 | 7 | | 5 |
---|
8 | 8 | | 6 |
---|
9 | 9 | | 7 |
---|
10 | 10 | | 8 |
---|
11 | 11 | | 9 |
---|
12 | 12 | | 10 |
---|
13 | 13 | | 11 |
---|
14 | 14 | | 12 |
---|
15 | 15 | | 13 |
---|
16 | 16 | | 14 |
---|
17 | 17 | | 15 |
---|
18 | 18 | | 16 |
---|
19 | 19 | | 17 |
---|
20 | 20 | | 18 |
---|
21 | 21 | | 19 |
---|
22 | 22 | | 20 |
---|
23 | 23 | | 21 |
---|
24 | 24 | | 22 |
---|
25 | 25 | | 23 |
---|
26 | 26 | | 24 |
---|
27 | 27 | | |
---|
28 | 28 | | STATE OF OKLAHOMA |
---|
29 | 29 | | |
---|
30 | 30 | | 1st Session of the 60th Legislature (2025) |
---|
31 | 31 | | |
---|
32 | 32 | | HOUSE BILL 1311 By: Humphrey |
---|
33 | 33 | | |
---|
34 | 34 | | |
---|
35 | 35 | | |
---|
36 | 36 | | |
---|
37 | 37 | | |
---|
38 | 38 | | AS INTRODUCED |
---|
39 | 39 | | |
---|
40 | 40 | | An Act relating to controlled dangerous substances; |
---|
41 | 41 | | amending 63 O.S. 2021, Section 2 -204, as last amended |
---|
42 | 42 | | by Section 3, Chapter 308, O. S.L. 2024 (63 O.S. Supp. |
---|
43 | 43 | | 2024, Section 2-204), which relates to the Uniform |
---|
44 | 44 | | Controlled Dangerous Substances Act; adding chemicals |
---|
45 | 45 | | to Schedule I; and providing an effective date . |
---|
46 | 46 | | |
---|
47 | 47 | | |
---|
48 | 48 | | |
---|
49 | 49 | | |
---|
50 | 50 | | |
---|
51 | 51 | | |
---|
52 | 52 | | BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: |
---|
53 | 53 | | SECTION 1. AMENDATORY 63 O.S. 2021, Section 2 -204, as |
---|
54 | 54 | | last amended by Section 3, Chapter 308, O.S.L. 2024 (63 O.S. Supp. |
---|
55 | 55 | | 2024, Section 2-204), is amended to read as follows: |
---|
56 | 56 | | Section 2-204. The controlled substances listed in this section |
---|
57 | 57 | | are included in Schedule I and include any material, compound, |
---|
58 | 58 | | mixture or preparation that contains any quantity of the following |
---|
59 | 59 | | hallucinogenic substances, their salts, isomers and salts of |
---|
60 | 60 | | isomers, unless specifically excepted, when the existence of these |
---|
61 | 61 | | salts, isomers and salts of isomers is possible within the specific |
---|
62 | 62 | | chemical designation. |
---|
63 | 63 | | |
---|
64 | 64 | | Req. No. 10084 Page 2 1 |
---|
65 | 65 | | 2 |
---|
66 | 66 | | 3 |
---|
67 | 67 | | 4 |
---|
68 | 68 | | 5 |
---|
69 | 69 | | 6 |
---|
70 | 70 | | 7 |
---|
71 | 71 | | 8 |
---|
72 | 72 | | 9 |
---|
73 | 73 | | 10 |
---|
74 | 74 | | 11 |
---|
75 | 75 | | 12 |
---|
76 | 76 | | 13 |
---|
77 | 77 | | 14 |
---|
78 | 78 | | 15 |
---|
79 | 79 | | 16 |
---|
80 | 80 | | 17 |
---|
81 | 81 | | 18 |
---|
82 | 82 | | 19 |
---|
83 | 83 | | 20 |
---|
84 | 84 | | 21 |
---|
85 | 85 | | 22 |
---|
86 | 86 | | 23 |
---|
87 | 87 | | 24 |
---|
88 | 88 | | |
---|
89 | 89 | | A. Any of the following opiates including their isomers, |
---|
90 | 90 | | esters, ethers, salts, and salts of isomers, esters, and ethers, |
---|
91 | 91 | | unless specifically excepted, when the exis tence of these isomers, |
---|
92 | 92 | | esters, ethers, and salts is possible within the specific chemical |
---|
93 | 93 | | designation: |
---|
94 | 94 | | 1. Acetylmethadol; |
---|
95 | 95 | | 2. Allylprodine; |
---|
96 | 96 | | 3. Alphacetylmethadol; |
---|
97 | 97 | | 4. Alphameprodine; |
---|
98 | 98 | | 5. Alphamethadol; |
---|
99 | 99 | | 6. Benzethidine; |
---|
100 | 100 | | 7. Betacetylmethadol; |
---|
101 | 101 | | 8. Betameprodine; |
---|
102 | 102 | | 9. Betamethadol; |
---|
103 | 103 | | 10. Betaprodine; |
---|
104 | 104 | | 11. Clonitazene; |
---|
105 | 105 | | 12. Dextromoramide; |
---|
106 | 106 | | 13. Dextrorphan (except its methyl ether); |
---|
107 | 107 | | 14. Diampromide; |
---|
108 | 108 | | 15. Diethylthiambutene; |
---|
109 | 109 | | 16. Dimenoxadol; |
---|
110 | 110 | | 17. Dimepheptanol; |
---|
111 | 111 | | 18. Dimethylthiambutene; |
---|
112 | 112 | | 19. Dioxaphetyl buty rate; |
---|
113 | 113 | | |
---|
114 | 114 | | Req. No. 10084 Page 3 1 |
---|
115 | 115 | | 2 |
---|
116 | 116 | | 3 |
---|
117 | 117 | | 4 |
---|
118 | 118 | | 5 |
---|
119 | 119 | | 6 |
---|
120 | 120 | | 7 |
---|
121 | 121 | | 8 |
---|
122 | 122 | | 9 |
---|
123 | 123 | | 10 |
---|
124 | 124 | | 11 |
---|
125 | 125 | | 12 |
---|
126 | 126 | | 13 |
---|
127 | 127 | | 14 |
---|
128 | 128 | | 15 |
---|
129 | 129 | | 16 |
---|
130 | 130 | | 17 |
---|
131 | 131 | | 18 |
---|
132 | 132 | | 19 |
---|
133 | 133 | | 20 |
---|
134 | 134 | | 21 |
---|
135 | 135 | | 22 |
---|
136 | 136 | | 23 |
---|
137 | 137 | | 24 |
---|
138 | 138 | | |
---|
139 | 139 | | 20. Dipipanone; |
---|
140 | 140 | | 21. Ethylmethylthiambutene; |
---|
141 | 141 | | 22. Etonitazene; |
---|
142 | 142 | | 23. Etoxeridine; |
---|
143 | 143 | | 24. Furethidine; |
---|
144 | 144 | | 25. Hydroxypethidine; |
---|
145 | 145 | | 26. Isotonitazene; |
---|
146 | 146 | | 27. Ketobemidone; |
---|
147 | 147 | | 28. Levomoramide; |
---|
148 | 148 | | 29. Levophenacylmorphan; |
---|
149 | 149 | | 30. Metonitazene; |
---|
150 | 150 | | 31. Morpheridine; |
---|
151 | 151 | | 32. N-desethyl isotonitazene; |
---|
152 | 152 | | 33. N-pyrrolidino protonitazene; |
---|
153 | 153 | | 34. Noracymethadol; |
---|
154 | 154 | | 35. Norlevorphanol; |
---|
155 | 155 | | 36. Normethadone; |
---|
156 | 156 | | 37. Norpipanone; |
---|
157 | 157 | | 38. Phenadoxone; |
---|
158 | 158 | | 39. Phenampromide; |
---|
159 | 159 | | 40. Phenomorphan; |
---|
160 | 160 | | 41. Phenoperidine; |
---|
161 | 161 | | 42. Piritramide; |
---|
162 | 162 | | 43. Proheptazine; |
---|
163 | 163 | | |
---|
164 | 164 | | Req. No. 10084 Page 4 1 |
---|
165 | 165 | | 2 |
---|
166 | 166 | | 3 |
---|
167 | 167 | | 4 |
---|
168 | 168 | | 5 |
---|
169 | 169 | | 6 |
---|
170 | 170 | | 7 |
---|
171 | 171 | | 8 |
---|
172 | 172 | | 9 |
---|
173 | 173 | | 10 |
---|
174 | 174 | | 11 |
---|
175 | 175 | | 12 |
---|
176 | 176 | | 13 |
---|
177 | 177 | | 14 |
---|
178 | 178 | | 15 |
---|
179 | 179 | | 16 |
---|
180 | 180 | | 17 |
---|
181 | 181 | | 18 |
---|
182 | 182 | | 19 |
---|
183 | 183 | | 20 |
---|
184 | 184 | | 21 |
---|
185 | 185 | | 22 |
---|
186 | 186 | | 23 |
---|
187 | 187 | | 24 |
---|
188 | 188 | | |
---|
189 | 189 | | 44. Properidine; |
---|
190 | 190 | | 45. Protonitazene; |
---|
191 | 191 | | 46. Racemoramide; or |
---|
192 | 192 | | 47. Trimeperidine. |
---|
193 | 193 | | B. Any of the following opium derivatives, their salts, |
---|
194 | 194 | | isomers, and salts of isomers, unless specifically excepted, when |
---|
195 | 195 | | the existence of these salts, isomers, and salts of isom ers is |
---|
196 | 196 | | possible within the specific chemical designation: |
---|
197 | 197 | | 1. Acetorphine; |
---|
198 | 198 | | 2. Acetyldihydrocodeine; |
---|
199 | 199 | | 3. Benzylmorphine; |
---|
200 | 200 | | 4. Codeine methylbromide; |
---|
201 | 201 | | 5. Codeine-N-Oxide; |
---|
202 | 202 | | 6. Cyprenorphine; |
---|
203 | 203 | | 7. Desomorphine; |
---|
204 | 204 | | 8. Dihydromorphine; |
---|
205 | 205 | | 9. Etorphine; |
---|
206 | 206 | | 10. Heroin; |
---|
207 | 207 | | 11. Hydromorphinol; |
---|
208 | 208 | | 12. Methyldesorphine; |
---|
209 | 209 | | 13. Methylhydromorphine; |
---|
210 | 210 | | 14. Morphine methylbromide; |
---|
211 | 211 | | 15. Morphine methylsulfonate; |
---|
212 | 212 | | 16. Morphine-N-Oxide; |
---|
213 | 213 | | |
---|
214 | 214 | | Req. No. 10084 Page 5 1 |
---|
215 | 215 | | 2 |
---|
216 | 216 | | 3 |
---|
217 | 217 | | 4 |
---|
218 | 218 | | 5 |
---|
219 | 219 | | 6 |
---|
220 | 220 | | 7 |
---|
221 | 221 | | 8 |
---|
222 | 222 | | 9 |
---|
223 | 223 | | 10 |
---|
224 | 224 | | 11 |
---|
225 | 225 | | 12 |
---|
226 | 226 | | 13 |
---|
227 | 227 | | 14 |
---|
228 | 228 | | 15 |
---|
229 | 229 | | 16 |
---|
230 | 230 | | 17 |
---|
231 | 231 | | 18 |
---|
232 | 232 | | 19 |
---|
233 | 233 | | 20 |
---|
234 | 234 | | 21 |
---|
235 | 235 | | 22 |
---|
236 | 236 | | 23 |
---|
237 | 237 | | 24 |
---|
238 | 238 | | |
---|
239 | 239 | | 17. Myrophine; |
---|
240 | 240 | | 18. Nicocodeine; |
---|
241 | 241 | | 19. Nicomorphine; |
---|
242 | 242 | | 20. Normorphine; |
---|
243 | 243 | | 21. Phoclodine; |
---|
244 | 244 | | 22. Thebacon; |
---|
245 | 245 | | 23. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-acetamide |
---|
246 | 246 | | (Acetyl fentanyl); |
---|
247 | 247 | | 24. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-butenamide |
---|
248 | 248 | | (Crotonyl fentanyl); |
---|
249 | 249 | | 25. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-2- |
---|
250 | 250 | | furancarboxamide (Furanyl fentanyl); |
---|
251 | 251 | | 26. N-phenyl-1-(2-phenylethyl)-4-piperidinamine (4-ANPP); |
---|
252 | 252 | | 27. N-(1-phenethylpiperidin-4-yl)-N- |
---|
253 | 253 | | phenylcyclopropanecarboxamide (Cyclopropyl fentanyl); or |
---|
254 | 254 | | 28. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide |
---|
255 | 255 | | (Butyrl fentanyl). |
---|
256 | 256 | | C. Any material, compound, mi xture, or preparation which |
---|
257 | 257 | | contains any quantity of the following hallucinoge nic substances, |
---|
258 | 258 | | their salts, isomers, and salts of isomers, unless specifically |
---|
259 | 259 | | excepted, when the existence of these salts, isomers, and salts of |
---|
260 | 260 | | isomers is possible within the specific chemical designation: |
---|
261 | 261 | | 1. Methcathinone; |
---|
262 | 262 | | 2. 3, 4-methylenedioxy amphetamine; |
---|
263 | 263 | | |
---|
264 | 264 | | Req. No. 10084 Page 6 1 |
---|
265 | 265 | | 2 |
---|
266 | 266 | | 3 |
---|
267 | 267 | | 4 |
---|
268 | 268 | | 5 |
---|
269 | 269 | | 6 |
---|
270 | 270 | | 7 |
---|
271 | 271 | | 8 |
---|
272 | 272 | | 9 |
---|
273 | 273 | | 10 |
---|
274 | 274 | | 11 |
---|
275 | 275 | | 12 |
---|
276 | 276 | | 13 |
---|
277 | 277 | | 14 |
---|
278 | 278 | | 15 |
---|
279 | 279 | | 16 |
---|
280 | 280 | | 17 |
---|
281 | 281 | | 18 |
---|
282 | 282 | | 19 |
---|
283 | 283 | | 20 |
---|
284 | 284 | | 21 |
---|
285 | 285 | | 22 |
---|
286 | 286 | | 23 |
---|
287 | 287 | | 24 |
---|
288 | 288 | | |
---|
289 | 289 | | 3. 3, 4-methylenedioxy methamphetamine; |
---|
290 | 290 | | 4. 5-methoxy-3, 4-methylenedioxy amphetamine; |
---|
291 | 291 | | 5. 3, 4, 5-trimethoxy amphetamine; |
---|
292 | 292 | | 6. Bufotenine; |
---|
293 | 293 | | 7. Diethyltryptamine; |
---|
294 | 294 | | 8. Dimethyltryptamine; |
---|
295 | 295 | | 9. 4-methyl-2, 5-dimethoxyamphetamine; |
---|
296 | 296 | | 10. Ibogaine; |
---|
297 | 297 | | 11. Lysergic acid diethylamide; |
---|
298 | 298 | | 12. Marijuana; |
---|
299 | 299 | | 13. Mescaline; |
---|
300 | 300 | | 14. N-benzylpiperazine; |
---|
301 | 301 | | 15. N-ethyl-3-piperidyl benzilate; |
---|
302 | 302 | | 16. N-methyl-3-piperidyl benzilate; |
---|
303 | 303 | | 17. Psilocybin; |
---|
304 | 304 | | 18. Psilocyn; |
---|
305 | 305 | | 19. 2, 5 dimethoxyamphetamine; |
---|
306 | 306 | | 20. 4 Bromo-2, 5-dimethoxyamphetamine; |
---|
307 | 307 | | 21. 4 methoxyamphetamine; |
---|
308 | 308 | | 22. Cyclohexamine; |
---|
309 | 309 | | 23. Salvia Divinorum; |
---|
310 | 310 | | 24. Salvinorin A; |
---|
311 | 311 | | |
---|
312 | 312 | | Req. No. 10084 Page 7 1 |
---|
313 | 313 | | 2 |
---|
314 | 314 | | 3 |
---|
315 | 315 | | 4 |
---|
316 | 316 | | 5 |
---|
317 | 317 | | 6 |
---|
318 | 318 | | 7 |
---|
319 | 319 | | 8 |
---|
320 | 320 | | 9 |
---|
321 | 321 | | 10 |
---|
322 | 322 | | 11 |
---|
323 | 323 | | 12 |
---|
324 | 324 | | 13 |
---|
325 | 325 | | 14 |
---|
326 | 326 | | 15 |
---|
327 | 327 | | 16 |
---|
328 | 328 | | 17 |
---|
329 | 329 | | 18 |
---|
330 | 330 | | 19 |
---|
331 | 331 | | 20 |
---|
332 | 332 | | 21 |
---|
333 | 333 | | 22 |
---|
334 | 334 | | 23 |
---|
335 | 335 | | 24 |
---|
336 | 336 | | |
---|
337 | 337 | | 25. Thiophene Analog of Phencyclidine. Also known as: 1 -(1-(2- |
---|
338 | 338 | | thienyl) cyclohexyl) piperidine; 2-Thienyl Analog of Phencyclidine; |
---|
339 | 339 | | TPCP, TCP; |
---|
340 | 340 | | 26. Phencyclidine (PCP); |
---|
341 | 341 | | 27. Pyrrolidine Analog for Phencyclidine. Also known as 1 -(1- |
---|
342 | 342 | | Phenylcyclohexyl) - Pyrrolidine, PCPy, PHP; |
---|
343 | 343 | | 28. 1-(3-trifluoromethylphenyl) piperazine; |
---|
344 | 344 | | 29. Flunitrazepam; |
---|
345 | 345 | | 30. B-hydroxy-amphetamine; |
---|
346 | 346 | | 31. B-ketoamphetamine; |
---|
347 | 347 | | 32. 2,5-dimethoxy-4-nitroamphetamine; |
---|
348 | 348 | | 33. 2,5-dimethoxy-4-bromophenethylamine; |
---|
349 | 349 | | 34. 2,5-dimethoxy-4-chlorophenethylamine; |
---|
350 | 350 | | 35. 2,5-dimethoxy-4-iodoamphetamine; |
---|
351 | 351 | | 36. 2,5-dimethoxy-4-iodophenethylamine; |
---|
352 | 352 | | 37. 2,5-dimethoxy-4-methylphenethylamine; |
---|
353 | 353 | | 38. 2,5-dimethoxy-4-ethylphenethylamine; |
---|
354 | 354 | | 39. 2,5-dimethoxy-4-fluorophenethylamine; |
---|
355 | 355 | | 40. 2,5-dimethoxy-4-nitrophenethylamine; |
---|
356 | 356 | | 41. 2,5-dimethoxy-4-ethylthio-phenethylamine; |
---|
357 | 357 | | 42. 2,5-dimethoxy-4-isopropylthio-phenethylamine; |
---|
358 | 358 | | 43. 2,5-dimethoxy-4-propylthio-phenethylamine; |
---|
359 | 359 | | 44. 2,5-dimethoxy-4-cyclopropylmethylthio -phenethylamine; |
---|
360 | 360 | | 45. 2,5-dimethoxy-4-tert-butylthio-phenethylamine; |
---|
361 | 361 | | |
---|
362 | 362 | | Req. No. 10084 Page 8 1 |
---|
363 | 363 | | 2 |
---|
364 | 364 | | 3 |
---|
365 | 365 | | 4 |
---|
366 | 366 | | 5 |
---|
367 | 367 | | 6 |
---|
368 | 368 | | 7 |
---|
369 | 369 | | 8 |
---|
370 | 370 | | 9 |
---|
371 | 371 | | 10 |
---|
372 | 372 | | 11 |
---|
373 | 373 | | 12 |
---|
374 | 374 | | 13 |
---|
375 | 375 | | 14 |
---|
376 | 376 | | 15 |
---|
377 | 377 | | 16 |
---|
378 | 378 | | 17 |
---|
379 | 379 | | 18 |
---|
380 | 380 | | 19 |
---|
381 | 381 | | 20 |
---|
382 | 382 | | 21 |
---|
383 | 383 | | 22 |
---|
384 | 384 | | 23 |
---|
385 | 385 | | 24 |
---|
386 | 386 | | |
---|
387 | 387 | | 46. 2,5-dimethoxy-4-(2-fluoroethylthio)-phenethylamine; |
---|
388 | 388 | | 47. 5-methoxy-N, N-dimethyltryptamine; |
---|
389 | 389 | | 48. N-methyltryptamine; |
---|
390 | 390 | | 49. A-ethyltryptamine; |
---|
391 | 391 | | 50. A-methyltryptamine; |
---|
392 | 392 | | 51. N, N-diethyltryptamine; |
---|
393 | 393 | | 52. N, N-diisopropyltryptamine; |
---|
394 | 394 | | 53. N, N-dipropyltryptamine; |
---|
395 | 395 | | 54. 5-methoxy-a-methyltryptamine; |
---|
396 | 396 | | 55. 4-hydroxy-N, N-diethyltryptamine; |
---|
397 | 397 | | 56. 4-hydroxy-N, N-diisopropyltryptamine; |
---|
398 | 398 | | 57. 5-methoxy-N, N-diisopropyltryptamine; |
---|
399 | 399 | | 58. 4-hydroxy-N-isopropyl-N-methyltryptamine; |
---|
400 | 400 | | 59. 3,4-Methylenedioxymethcathinone (Methylone); |
---|
401 | 401 | | 60. 3,4-Methylenedioxypyrovalerone (MDPV); |
---|
402 | 402 | | 61. 3-Methylmethcathinone (Meta phedrone); |
---|
403 | 403 | | 62. 4-Methylmethcathinone (Mephedrone); |
---|
404 | 404 | | 63. 4-methoxymethcathinone; |
---|
405 | 405 | | 64. 4-Fluoromethcathinone; |
---|
406 | 406 | | 65. 3-Fluoromethcathinone; |
---|
407 | 407 | | 66. 1-(8-bromobenzo 1,2-b;4,5-b' difuran-4-yl)-2-aminopropane; |
---|
408 | 408 | | 67. 2,5-Dimethoxy-4-chloroamphetamine; |
---|
409 | 409 | | 68. 4-Methylethcathinone; |
---|
410 | 410 | | 69. Pyrovalerone; |
---|
411 | 411 | | |
---|
412 | 412 | | Req. No. 10084 Page 9 1 |
---|
413 | 413 | | 2 |
---|
414 | 414 | | 3 |
---|
415 | 415 | | 4 |
---|
416 | 416 | | 5 |
---|
417 | 417 | | 6 |
---|
418 | 418 | | 7 |
---|
419 | 419 | | 8 |
---|
420 | 420 | | 9 |
---|
421 | 421 | | 10 |
---|
422 | 422 | | 11 |
---|
423 | 423 | | 12 |
---|
424 | 424 | | 13 |
---|
425 | 425 | | 14 |
---|
426 | 426 | | 15 |
---|
427 | 427 | | 16 |
---|
428 | 428 | | 17 |
---|
429 | 429 | | 18 |
---|
430 | 430 | | 19 |
---|
431 | 431 | | 20 |
---|
432 | 432 | | 21 |
---|
433 | 433 | | 22 |
---|
434 | 434 | | 23 |
---|
435 | 435 | | 24 |
---|
436 | 436 | | |
---|
437 | 437 | | 70. N,N-diallyl-5-methoxytryptamine; |
---|
438 | 438 | | 71. 3,4-Methylenedioxy-N-ethylcathinone (Ethylone); |
---|
439 | 439 | | 72. B-keto-N-Methylbenzodioxolylbutanamine (Butylone); |
---|
440 | 440 | | 73. B-keto-Methylbenzodioxolylpentanamine (Pentylone); |
---|
441 | 441 | | 74. Alpha-Pyrrolidinopentiophenone; |
---|
442 | 442 | | 75. 4-Fluoroamphetamine; |
---|
443 | 443 | | 76. Pentedrone; |
---|
444 | 444 | | 77. 4'-Methyl-a-pyrrolidinohexaphenone; |
---|
445 | 445 | | 78. 2,5-dimethoxy-4-(n)-propylphenethylamine; |
---|
446 | 446 | | 79. 2,5-dimethoxyphenethylamine; |
---|
447 | 447 | | 80. 1,4-Dibenzylpiperazine; |
---|
448 | 448 | | 81. N,N-Dimethylamphetamine; |
---|
449 | 449 | | 82. 4-Fluoromethamphetamine; |
---|
450 | 450 | | 83. 4-Chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine |
---|
451 | 451 | | (25C-NBOMe); |
---|
452 | 452 | | 84. 4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine |
---|
453 | 453 | | (25I-NBOMe); |
---|
454 | 454 | | 85. 4-Bromo-2,5-dimethoxy-N-(2-methoxybenzy)phenethylamine |
---|
455 | 455 | | (25B-NBOMe); |
---|
456 | 456 | | 86. 1-(4-Fluorophenyl)piperazine; |
---|
457 | 457 | | 87. Methoxetamine; |
---|
458 | 458 | | 88. 3,4-dichloro-N[2-dimethylamino)cyclohexy l]-N- |
---|
459 | 459 | | methylbenzamide; |
---|
460 | 460 | | 89. N-ethyl hexadrone; |
---|
461 | 461 | | |
---|
462 | 462 | | Req. No. 10084 Page 10 1 |
---|
463 | 463 | | 2 |
---|
464 | 464 | | 3 |
---|
465 | 465 | | 4 |
---|
466 | 466 | | 5 |
---|
467 | 467 | | 6 |
---|
468 | 468 | | 7 |
---|
469 | 469 | | 8 |
---|
470 | 470 | | 9 |
---|
471 | 471 | | 10 |
---|
472 | 472 | | 11 |
---|
473 | 473 | | 12 |
---|
474 | 474 | | 13 |
---|
475 | 475 | | 14 |
---|
476 | 476 | | 15 |
---|
477 | 477 | | 16 |
---|
478 | 478 | | 17 |
---|
479 | 479 | | 18 |
---|
480 | 480 | | 19 |
---|
481 | 481 | | 20 |
---|
482 | 482 | | 21 |
---|
483 | 483 | | 22 |
---|
484 | 484 | | 23 |
---|
485 | 485 | | 24 |
---|
486 | 486 | | |
---|
487 | 487 | | 90. Isopropyl-U-47700; |
---|
488 | 488 | | 91. Para-fluorobutyrl fentanyl; |
---|
489 | 489 | | 92. Para-fluorofentanyl (pFF); |
---|
490 | 490 | | 93. Fluoro isobutryrl fentanyl; |
---|
491 | 491 | | 94. 3-Hydroxy Phencyclidine (PCP); |
---|
492 | 492 | | 95. 3-methoxy Phencyclidine (PCP); |
---|
493 | 493 | | 96. Flualprazolam; or |
---|
494 | 494 | | 97. Flubromazolam; |
---|
495 | 495 | | 98. Ethyleneoxynitazene; |
---|
496 | 496 | | 99. 5-Methyl Etodesnitazene; |
---|
497 | 497 | | 100. 3', 4' Methylenedioxynitazene; |
---|
498 | 498 | | 101. N-Pyrrolidino Isotonitazene; |
---|
499 | 499 | | 102. N-Desethyl Etonitazene; or |
---|
500 | 500 | | 103. Ethylene Etonitazene . |
---|
501 | 501 | | D. Unless specifically excepted or unless l isted in a different |
---|
502 | 502 | | schedule, any material, compound, mixture, or preparation which |
---|
503 | 503 | | contains any quantity of the following substances having stimulant |
---|
504 | 504 | | or depressant effect on th e central nervous system: |
---|
505 | 505 | | 1. Fenethylline; |
---|
506 | 506 | | 2. Mecloqualone; |
---|
507 | 507 | | 3. N-ethylamphetamine; |
---|
508 | 508 | | 4. Methaqualone; |
---|
509 | 509 | | |
---|
510 | 510 | | Req. No. 10084 Page 11 1 |
---|
511 | 511 | | 2 |
---|
512 | 512 | | 3 |
---|
513 | 513 | | 4 |
---|
514 | 514 | | 5 |
---|
515 | 515 | | 6 |
---|
516 | 516 | | 7 |
---|
517 | 517 | | 8 |
---|
518 | 518 | | 9 |
---|
519 | 519 | | 10 |
---|
520 | 520 | | 11 |
---|
521 | 521 | | 12 |
---|
522 | 522 | | 13 |
---|
523 | 523 | | 14 |
---|
524 | 524 | | 15 |
---|
525 | 525 | | 16 |
---|
526 | 526 | | 17 |
---|
527 | 527 | | 18 |
---|
528 | 528 | | 19 |
---|
529 | 529 | | 20 |
---|
530 | 530 | | 21 |
---|
531 | 531 | | 22 |
---|
532 | 532 | | 23 |
---|
533 | 533 | | 24 |
---|
534 | 534 | | |
---|
535 | 535 | | 5. Gamma-Hydroxybutyric Acid, also known as GHB, gamma - |
---|
536 | 536 | | hydroxybutyrate, 4-hydroxybutyrate, 4-hydroxybutanoic acid, sodium |
---|
537 | 537 | | oxybate, and sodium oxybutyra te; |
---|
538 | 538 | | 6. Gamma-Butyrolactone (GBL) as packaged, marketed, |
---|
539 | 539 | | manufactured or promo ted for human consumption, with the exception |
---|
540 | 540 | | of legitimate food additive and manufacturing purposes; |
---|
541 | 541 | | 7. Gamma Hydroxyvalerate (GHV) as packaged, marketed, or |
---|
542 | 542 | | manufactured for human consumption, with the exception of legitimate |
---|
543 | 543 | | food additive and manufacturing purposes; |
---|
544 | 544 | | 8. Gamma Valerolactone (GVL) as packaged, marketed, or |
---|
545 | 545 | | manufactured for human consumption, with the exception of legitimate |
---|
546 | 546 | | food additive and manufacturing purpos es; |
---|
547 | 547 | | 9. 1,4 Butanediol (1,4 BD or BDO) as packaged, marketed, |
---|
548 | 548 | | manufactured, or promoted for human consumption with the exception |
---|
549 | 549 | | of legitimate manufacturing purposes; or |
---|
550 | 550 | | 10. N-ethylpentylone. |
---|
551 | 551 | | E. 1. The following industrial uses of Gamma -Butyrolactone, |
---|
552 | 552 | | Gamma Hydroxyvalerate, Gamma Valerolactone, or 1,4 Butanediol are |
---|
553 | 553 | | excluded from all schedules of controlled substances under this |
---|
554 | 554 | | title: |
---|
555 | 555 | | a. pesticides, |
---|
556 | 556 | | b. photochemical etching, |
---|
557 | 557 | | c. electrolytes of small batteries or capacitors, |
---|
558 | 558 | | d. viscosity modifiers in pol yurethane, |
---|
559 | 559 | | |
---|
560 | 560 | | Req. No. 10084 Page 12 1 |
---|
561 | 561 | | 2 |
---|
562 | 562 | | 3 |
---|
563 | 563 | | 4 |
---|
564 | 564 | | 5 |
---|
565 | 565 | | 6 |
---|
566 | 566 | | 7 |
---|
567 | 567 | | 8 |
---|
568 | 568 | | 9 |
---|
569 | 569 | | 10 |
---|
570 | 570 | | 11 |
---|
571 | 571 | | 12 |
---|
572 | 572 | | 13 |
---|
573 | 573 | | 14 |
---|
574 | 574 | | 15 |
---|
575 | 575 | | 16 |
---|
576 | 576 | | 17 |
---|
577 | 577 | | 18 |
---|
578 | 578 | | 19 |
---|
579 | 579 | | 20 |
---|
580 | 580 | | 21 |
---|
581 | 581 | | 22 |
---|
582 | 582 | | 23 |
---|
583 | 583 | | 24 |
---|
584 | 584 | | |
---|
585 | 585 | | e. surface etching of metal coated plastics, |
---|
586 | 586 | | f. organic paint disbursements for water soluble inks, |
---|
587 | 587 | | g. pH regulators in the dyeing of wool and polyamide |
---|
588 | 588 | | fibers, |
---|
589 | 589 | | h. foundry chemistry as a catalyst during curing, |
---|
590 | 590 | | i. curing agents in many coating s ystems based on |
---|
591 | 591 | | urethanes and amides, |
---|
592 | 592 | | j. additives and flavoring agents in food, confectionary, |
---|
593 | 593 | | and beverage products, |
---|
594 | 594 | | k. synthetic fiber and clothing production, |
---|
595 | 595 | | l. tetrahydrofuran production, |
---|
596 | 596 | | m. gamma butyrolactone production, |
---|
597 | 597 | | n. polybutylene terephthala te resin production, |
---|
598 | 598 | | o. polyester raw materials for polyurethane elastomers |
---|
599 | 599 | | and foams, |
---|
600 | 600 | | p. coating resin raw material, and |
---|
601 | 601 | | q. as an intermediate in the manufacture of other |
---|
602 | 602 | | chemicals and pharmaceuticals. |
---|
603 | 603 | | 2. At the request of any person, the Director of the Oklahoma |
---|
604 | 604 | | State Bureau of Narcotics and Dangerous Drugs Control may exempt any |
---|
605 | 605 | | other product containing Gamma -Butyrolactone, Gamma Hydroxyvalerate, |
---|
606 | 606 | | Gamma Valerolactone, or 1,4 Butanediol from being included as a |
---|
607 | 607 | | Schedule I controlled substance if such prod uct is labeled, |
---|
608 | 608 | | |
---|
609 | 609 | | Req. No. 10084 Page 13 1 |
---|
610 | 610 | | 2 |
---|
611 | 611 | | 3 |
---|
612 | 612 | | 4 |
---|
613 | 613 | | 5 |
---|
614 | 614 | | 6 |
---|
615 | 615 | | 7 |
---|
616 | 616 | | 8 |
---|
617 | 617 | | 9 |
---|
618 | 618 | | 10 |
---|
619 | 619 | | 11 |
---|
620 | 620 | | 12 |
---|
621 | 621 | | 13 |
---|
622 | 622 | | 14 |
---|
623 | 623 | | 15 |
---|
624 | 624 | | 16 |
---|
625 | 625 | | 17 |
---|
626 | 626 | | 18 |
---|
627 | 627 | | 19 |
---|
628 | 628 | | 20 |
---|
629 | 629 | | 21 |
---|
630 | 630 | | 22 |
---|
631 | 631 | | 23 |
---|
632 | 632 | | 24 |
---|
633 | 633 | | |
---|
634 | 634 | | marketed, manufactured and distributed for legitimate industri al use |
---|
635 | 635 | | in a manner that reduces or eliminates the likelihood of abuse. |
---|
636 | 636 | | 3. In making a determination regarding an industrial product, |
---|
637 | 637 | | the Director, after notice and hearing, shal l consider the |
---|
638 | 638 | | following: |
---|
639 | 639 | | a. the history and current pattern of abuse, |
---|
640 | 640 | | b. the name and labeling of the product, |
---|
641 | 641 | | c. the intended manner of distribution, advertising and |
---|
642 | 642 | | promotion of the product, and |
---|
643 | 643 | | d. other factors as may be relevant to and consistent |
---|
644 | 644 | | with the public health and safety. |
---|
645 | 645 | | 4. The hearing shall be held in accordance wit h the procedures |
---|
646 | 646 | | of the Administrative Procedures Act. |
---|
647 | 647 | | F. Any material, compound, mixture, or preparation, whether |
---|
648 | 648 | | produced directly or indirectly from a substance of vegetable origin |
---|
649 | 649 | | or independently by means of chemical synthesis, or by a combination |
---|
650 | 650 | | of extraction and chemical synthesis, that contains any quantity of |
---|
651 | 651 | | the following substances, or that contains any of their salts, |
---|
652 | 652 | | isomers, and salts of isomers when the existence of these salts, |
---|
653 | 653 | | isomers, and salts of isomers is possible within the specific |
---|
654 | 654 | | chemical designation: |
---|
655 | 655 | | 1. JWH-004; |
---|
656 | 656 | | 2. JWH-007; |
---|
657 | 657 | | 3. JWH-009; |
---|
658 | 658 | | |
---|
659 | 659 | | Req. No. 10084 Page 14 1 |
---|
660 | 660 | | 2 |
---|
661 | 661 | | 3 |
---|
662 | 662 | | 4 |
---|
663 | 663 | | 5 |
---|
664 | 664 | | 6 |
---|
665 | 665 | | 7 |
---|
666 | 666 | | 8 |
---|
667 | 667 | | 9 |
---|
668 | 668 | | 10 |
---|
669 | 669 | | 11 |
---|
670 | 670 | | 12 |
---|
671 | 671 | | 13 |
---|
672 | 672 | | 14 |
---|
673 | 673 | | 15 |
---|
674 | 674 | | 16 |
---|
675 | 675 | | 17 |
---|
676 | 676 | | 18 |
---|
677 | 677 | | 19 |
---|
678 | 678 | | 20 |
---|
679 | 679 | | 21 |
---|
680 | 680 | | 22 |
---|
681 | 681 | | 23 |
---|
682 | 682 | | 24 |
---|
683 | 683 | | |
---|
684 | 684 | | 4. JWH-015; |
---|
685 | 685 | | 5. JWH-016; |
---|
686 | 686 | | 6. JWH-018; |
---|
687 | 687 | | 7. JWH-019; |
---|
688 | 688 | | 8. JWH-020; |
---|
689 | 689 | | 9. JWH-030; |
---|
690 | 690 | | 10. JWH-046; |
---|
691 | 691 | | 11. JWH-047; |
---|
692 | 692 | | 12. JWH-048; |
---|
693 | 693 | | 13. JWH-049; |
---|
694 | 694 | | 14. JWH-050; |
---|
695 | 695 | | 15. JWH-070; |
---|
696 | 696 | | 16. JWH-071; |
---|
697 | 697 | | 17. JWH-072; |
---|
698 | 698 | | 18. JWH-073; |
---|
699 | 699 | | 19. JWH-076; |
---|
700 | 700 | | 20. JWH-079; |
---|
701 | 701 | | 21. JWH-080; |
---|
702 | 702 | | 22. JWH-081; |
---|
703 | 703 | | 23. JWH-082; |
---|
704 | 704 | | 24. JWH-094; |
---|
705 | 705 | | 25. JWH-096; |
---|
706 | 706 | | 26. JWH-098; |
---|
707 | 707 | | 27. JWH-116; |
---|
708 | 708 | | |
---|
709 | 709 | | Req. No. 10084 Page 15 1 |
---|
710 | 710 | | 2 |
---|
711 | 711 | | 3 |
---|
712 | 712 | | 4 |
---|
713 | 713 | | 5 |
---|
714 | 714 | | 6 |
---|
715 | 715 | | 7 |
---|
716 | 716 | | 8 |
---|
717 | 717 | | 9 |
---|
718 | 718 | | 10 |
---|
719 | 719 | | 11 |
---|
720 | 720 | | 12 |
---|
721 | 721 | | 13 |
---|
722 | 722 | | 14 |
---|
723 | 723 | | 15 |
---|
724 | 724 | | 16 |
---|
725 | 725 | | 17 |
---|
726 | 726 | | 18 |
---|
727 | 727 | | 19 |
---|
728 | 728 | | 20 |
---|
729 | 729 | | 21 |
---|
730 | 730 | | 22 |
---|
731 | 731 | | 23 |
---|
732 | 732 | | 24 |
---|
733 | 733 | | |
---|
734 | 734 | | 28. JWH-120; |
---|
735 | 735 | | 29. JWH-122; |
---|
736 | 736 | | 30. JWH-145; |
---|
737 | 737 | | 31. JWH-146; |
---|
738 | 738 | | 32. JWH-147; |
---|
739 | 739 | | 33. JWH-148; |
---|
740 | 740 | | 34. JWH-149; |
---|
741 | 741 | | 35. JWH-150; |
---|
742 | 742 | | 36. JWH-156; |
---|
743 | 743 | | 37. JWH-167; |
---|
744 | 744 | | 38. JWH-175; |
---|
745 | 745 | | 39. JWH-180; |
---|
746 | 746 | | 40. JWH-181; |
---|
747 | 747 | | 41. JWH-182; |
---|
748 | 748 | | 42. JWH-184; |
---|
749 | 749 | | 43. JWH-185; |
---|
750 | 750 | | 44. JWH-189; |
---|
751 | 751 | | 45. JWH-192; |
---|
752 | 752 | | 46. JWH-193; |
---|
753 | 753 | | 47. JWH-194; |
---|
754 | 754 | | 48. JWH-195; |
---|
755 | 755 | | 49. JWH-196; |
---|
756 | 756 | | 50. JWH-197; |
---|
757 | 757 | | 51. JWH-198; |
---|
758 | 758 | | |
---|
759 | 759 | | Req. No. 10084 Page 16 1 |
---|
760 | 760 | | 2 |
---|
761 | 761 | | 3 |
---|
762 | 762 | | 4 |
---|
763 | 763 | | 5 |
---|
764 | 764 | | 6 |
---|
765 | 765 | | 7 |
---|
766 | 766 | | 8 |
---|
767 | 767 | | 9 |
---|
768 | 768 | | 10 |
---|
769 | 769 | | 11 |
---|
770 | 770 | | 12 |
---|
771 | 771 | | 13 |
---|
772 | 772 | | 14 |
---|
773 | 773 | | 15 |
---|
774 | 774 | | 16 |
---|
775 | 775 | | 17 |
---|
776 | 776 | | 18 |
---|
777 | 777 | | 19 |
---|
778 | 778 | | 20 |
---|
779 | 779 | | 21 |
---|
780 | 780 | | 22 |
---|
781 | 781 | | 23 |
---|
782 | 782 | | 24 |
---|
783 | 783 | | |
---|
784 | 784 | | 52. JWH-199; |
---|
785 | 785 | | 53. JWH-200; |
---|
786 | 786 | | 54. JWH-201; |
---|
787 | 787 | | 55. JWH-202; |
---|
788 | 788 | | 56. JWH-203; |
---|
789 | 789 | | 57. JWH-204; |
---|
790 | 790 | | 58. JWH-205; |
---|
791 | 791 | | 59. JWH-206; |
---|
792 | 792 | | 60. JWH-207; |
---|
793 | 793 | | 61. JWH-208; |
---|
794 | 794 | | 62. JWH-209; |
---|
795 | 795 | | 63. JWH-210; |
---|
796 | 796 | | 64. JWH-211; |
---|
797 | 797 | | 65. JWH-212; |
---|
798 | 798 | | 66. JWH-213; |
---|
799 | 799 | | 67. JWH-234; |
---|
800 | 800 | | 68. JWH-235; |
---|
801 | 801 | | 69. JWH-236; |
---|
802 | 802 | | 70. JWH-237; |
---|
803 | 803 | | 71. JWH-239; |
---|
804 | 804 | | 72. JWH-240; |
---|
805 | 805 | | 73. JWH-241; |
---|
806 | 806 | | 74. JWH-242; |
---|
807 | 807 | | 75. JWH-243; |
---|
808 | 808 | | |
---|
809 | 809 | | Req. No. 10084 Page 17 1 |
---|
810 | 810 | | 2 |
---|
811 | 811 | | 3 |
---|
812 | 812 | | 4 |
---|
813 | 813 | | 5 |
---|
814 | 814 | | 6 |
---|
815 | 815 | | 7 |
---|
816 | 816 | | 8 |
---|
817 | 817 | | 9 |
---|
818 | 818 | | 10 |
---|
819 | 819 | | 11 |
---|
820 | 820 | | 12 |
---|
821 | 821 | | 13 |
---|
822 | 822 | | 14 |
---|
823 | 823 | | 15 |
---|
824 | 824 | | 16 |
---|
825 | 825 | | 17 |
---|
826 | 826 | | 18 |
---|
827 | 827 | | 19 |
---|
828 | 828 | | 20 |
---|
829 | 829 | | 21 |
---|
830 | 830 | | 22 |
---|
831 | 831 | | 23 |
---|
832 | 832 | | 24 |
---|
833 | 833 | | |
---|
834 | 834 | | 76. JWH-244; |
---|
835 | 835 | | 77. JWH-245; |
---|
836 | 836 | | 78. JWH-246; |
---|
837 | 837 | | 79. JWH-248; |
---|
838 | 838 | | 80. JWH-249; |
---|
839 | 839 | | 81. JWH-250; |
---|
840 | 840 | | 82. JWH-251; |
---|
841 | 841 | | 83. JWH-252; |
---|
842 | 842 | | 84. JWH-253; |
---|
843 | 843 | | 85. JWH-262; |
---|
844 | 844 | | 86. JWH-292; |
---|
845 | 845 | | 87. JWH-293; |
---|
846 | 846 | | 88. JWH-302; |
---|
847 | 847 | | 89. JWH-303; |
---|
848 | 848 | | 90. JWH-304; |
---|
849 | 849 | | 91. JWH-305; |
---|
850 | 850 | | 92. JWH-306; |
---|
851 | 851 | | 93. JWH-307; |
---|
852 | 852 | | 94. JWH-308; |
---|
853 | 853 | | 95. JWH-311; |
---|
854 | 854 | | 96. JWH-312; |
---|
855 | 855 | | 97. JWH-313; |
---|
856 | 856 | | 98. JWH-314; |
---|
857 | 857 | | 99. JWH-315; |
---|
858 | 858 | | |
---|
859 | 859 | | Req. No. 10084 Page 18 1 |
---|
860 | 860 | | 2 |
---|
861 | 861 | | 3 |
---|
862 | 862 | | 4 |
---|
863 | 863 | | 5 |
---|
864 | 864 | | 6 |
---|
865 | 865 | | 7 |
---|
866 | 866 | | 8 |
---|
867 | 867 | | 9 |
---|
868 | 868 | | 10 |
---|
869 | 869 | | 11 |
---|
870 | 870 | | 12 |
---|
871 | 871 | | 13 |
---|
872 | 872 | | 14 |
---|
873 | 873 | | 15 |
---|
874 | 874 | | 16 |
---|
875 | 875 | | 17 |
---|
876 | 876 | | 18 |
---|
877 | 877 | | 19 |
---|
878 | 878 | | 20 |
---|
879 | 879 | | 21 |
---|
880 | 880 | | 22 |
---|
881 | 881 | | 23 |
---|
882 | 882 | | 24 |
---|
883 | 883 | | |
---|
884 | 884 | | 100. JWH-316; |
---|
885 | 885 | | 101. JWH-346; |
---|
886 | 886 | | 102. JWH-348; |
---|
887 | 887 | | 103. JWH-363; |
---|
888 | 888 | | 104. JWH-364; |
---|
889 | 889 | | 105. JWH-365; |
---|
890 | 890 | | 106. JWH-367; |
---|
891 | 891 | | 107. JWH-368; |
---|
892 | 892 | | 108. JWH-369; |
---|
893 | 893 | | 109. JWH-370; |
---|
894 | 894 | | 110. JWH-371; |
---|
895 | 895 | | 111. JWH-373; |
---|
896 | 896 | | 112. JWH-386; |
---|
897 | 897 | | 113. JWH-387; |
---|
898 | 898 | | 114. JWH-392; |
---|
899 | 899 | | 115. JWH-394; |
---|
900 | 900 | | 116. JWH-395; |
---|
901 | 901 | | 117. JWH-397; |
---|
902 | 902 | | 118. JWH-398; |
---|
903 | 903 | | 119. JWH-399; |
---|
904 | 904 | | 120. JWH-400; |
---|
905 | 905 | | 121. JWH-412; |
---|
906 | 906 | | 122. JWH-413; |
---|
907 | 907 | | 123. JWH-414; |
---|
908 | 908 | | |
---|
909 | 909 | | Req. No. 10084 Page 19 1 |
---|
910 | 910 | | 2 |
---|
911 | 911 | | 3 |
---|
912 | 912 | | 4 |
---|
913 | 913 | | 5 |
---|
914 | 914 | | 6 |
---|
915 | 915 | | 7 |
---|
916 | 916 | | 8 |
---|
917 | 917 | | 9 |
---|
918 | 918 | | 10 |
---|
919 | 919 | | 11 |
---|
920 | 920 | | 12 |
---|
921 | 921 | | 13 |
---|
922 | 922 | | 14 |
---|
923 | 923 | | 15 |
---|
924 | 924 | | 16 |
---|
925 | 925 | | 17 |
---|
926 | 926 | | 18 |
---|
927 | 927 | | 19 |
---|
928 | 928 | | 20 |
---|
929 | 929 | | 21 |
---|
930 | 930 | | 22 |
---|
931 | 931 | | 23 |
---|
932 | 932 | | 24 |
---|
933 | 933 | | |
---|
934 | 934 | | 124. JWH-415; |
---|
935 | 935 | | 125. CP-55, 940; |
---|
936 | 936 | | 126. CP-47, 497; |
---|
937 | 937 | | 127. HU-210; |
---|
938 | 938 | | 128. HU-211; |
---|
939 | 939 | | 129. WIN-55, 212-2; |
---|
940 | 940 | | 130. AM-2201; |
---|
941 | 941 | | 131. AM-2233; |
---|
942 | 942 | | 132. JWH-018 adamantyl-carboxamide; |
---|
943 | 943 | | 133. AKB48; |
---|
944 | 944 | | 134. JWH-122 N-(4-pentenyl)analog; |
---|
945 | 945 | | 135. MAM2201; |
---|
946 | 946 | | 136. URB597; |
---|
947 | 947 | | 137. URB602; |
---|
948 | 948 | | 138. URB754; |
---|
949 | 949 | | 139. UR144; |
---|
950 | 950 | | 140. XLR11; |
---|
951 | 951 | | 141. A-796,260; |
---|
952 | 952 | | 142. STS-135; |
---|
953 | 953 | | 143. AB-FUBINACA; |
---|
954 | 954 | | 144. AB-PINACA; |
---|
955 | 955 | | 145. PB-22; |
---|
956 | 956 | | 146. AKB48 N-5-Fluorpentyl; |
---|
957 | 957 | | 147. AM1248; |
---|
958 | 958 | | |
---|
959 | 959 | | Req. No. 10084 Page 20 1 |
---|
960 | 960 | | 2 |
---|
961 | 961 | | 3 |
---|
962 | 962 | | 4 |
---|
963 | 963 | | 5 |
---|
964 | 964 | | 6 |
---|
965 | 965 | | 7 |
---|
966 | 966 | | 8 |
---|
967 | 967 | | 9 |
---|
968 | 968 | | 10 |
---|
969 | 969 | | 11 |
---|
970 | 970 | | 12 |
---|
971 | 971 | | 13 |
---|
972 | 972 | | 14 |
---|
973 | 973 | | 15 |
---|
974 | 974 | | 16 |
---|
975 | 975 | | 17 |
---|
976 | 976 | | 18 |
---|
977 | 977 | | 19 |
---|
978 | 978 | | 20 |
---|
979 | 979 | | 21 |
---|
980 | 980 | | 22 |
---|
981 | 981 | | 23 |
---|
982 | 982 | | 24 |
---|
983 | 983 | | |
---|
984 | 984 | | 148. FUB-PB-22; |
---|
985 | 985 | | 149. ADB-FUBINACA; |
---|
986 | 986 | | 150. BB-22; |
---|
987 | 987 | | 151. 5-Fluoro PB-22; or |
---|
988 | 988 | | 152. 5-Fluoro AKB-48. |
---|
989 | 989 | | G. In addition to those substances listed in subsection F of |
---|
990 | 990 | | this section, unless specifically excepted or unless listed in |
---|
991 | 991 | | another schedule, any material, compound, mixture, or preparation |
---|
992 | 992 | | which contains any quantity of a synthetic cannabinoid found to be |
---|
993 | 993 | | in any of the followin g chemical groups: |
---|
994 | 994 | | 1. Naphthoylindoles: any compound containing a 3 -(1- |
---|
995 | 995 | | naphthoyl)indole structure with or without substitution at the |
---|
996 | 996 | | nitrogen atom of the indole ring by an alk yl, haloalkyl, cyanoalkyl, |
---|
997 | 997 | | alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1 - |
---|
998 | 998 | | (N-methyl-2-piperidinyl)methyl, 2 -(4-morpholinyl)ethyl, 1 -(N-methyl- |
---|
999 | 999 | | 2-pyrrolidinyl)methyl, 1 -(N-methyl-3- morpholinyl)methyl, |
---|
1000 | 1000 | | (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or |
---|
1001 | 1001 | | halophenyl group, whether or not further substituted on the indole |
---|
1002 | 1002 | | ring to any extent, and whether or not substituted on the naphthyl |
---|
1003 | 1003 | | ring to any extent. Naphthoylindoles include, but are not limited |
---|
1004 | 1004 | | to: |
---|
1005 | 1005 | | a. 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH - |
---|
1006 | 1006 | | 200), |
---|
1007 | 1007 | | b. 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201), |
---|
1008 | 1008 | | |
---|
1009 | 1009 | | Req. No. 10084 Page 21 1 |
---|
1010 | 1010 | | 2 |
---|
1011 | 1011 | | 3 |
---|
1012 | 1012 | | 4 |
---|
1013 | 1013 | | 5 |
---|
1014 | 1014 | | 6 |
---|
1015 | 1015 | | 7 |
---|
1016 | 1016 | | 8 |
---|
1017 | 1017 | | 9 |
---|
1018 | 1018 | | 10 |
---|
1019 | 1019 | | 11 |
---|
1020 | 1020 | | 12 |
---|
1021 | 1021 | | 13 |
---|
1022 | 1022 | | 14 |
---|
1023 | 1023 | | 15 |
---|
1024 | 1024 | | 16 |
---|
1025 | 1025 | | 17 |
---|
1026 | 1026 | | 18 |
---|
1027 | 1027 | | 19 |
---|
1028 | 1028 | | 20 |
---|
1029 | 1029 | | 21 |
---|
1030 | 1030 | | 22 |
---|
1031 | 1031 | | 23 |
---|
1032 | 1032 | | 24 |
---|
1033 | 1033 | | |
---|
1034 | 1034 | | c. 1-pentyl-3-(1-naphthoyl)indole (JWH -018), |
---|
1035 | 1035 | | d. 1-butyl-3-(1-naphthoyl)indole (JWH -073), |
---|
1036 | 1036 | | e. 1-pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH -081), |
---|
1037 | 1037 | | f. 1-propyl-2-methyl-3-(1-naphthoyl)indole (JWH -015), |
---|
1038 | 1038 | | g. 1-hexyl-3-(1-naphthoyl)indole (JWH -019), |
---|
1039 | 1039 | | h. 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH -122), |
---|
1040 | 1040 | | i. 1-pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH -210), |
---|
1041 | 1041 | | j. 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH -398), |
---|
1042 | 1042 | | k. 1-pentyl-2-methyl-3-(1-naphthoyl)indole (JWH -007), |
---|
1043 | 1043 | | l. 1-pentyl-3-(7-methoxy-1-naphthoyl)indole (JWH -164), |
---|
1044 | 1044 | | m. 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole |
---|
1045 | 1045 | | (JWH-098), |
---|
1046 | 1046 | | n. 1-pentyl-3-(4-fluoro-1-naphthoyl)indole (JWH -412), |
---|
1047 | 1047 | | o. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(1- |
---|
1048 | 1048 | | naphthoyl)indole (AM-1220), |
---|
1049 | 1049 | | p. 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole |
---|
1050 | 1050 | | (MAM-2201), or |
---|
1051 | 1051 | | q. 1-(4-cyanobutyl)-3-(1-naphthoyl)indole (AM -2232); |
---|
1052 | 1052 | | 2. Naphthylmethylindoles: any compound containing a 1H -indol- |
---|
1053 | 1053 | | 3-yl-(1-naphthyl)methane structure with or withou t substitution at |
---|
1054 | 1054 | | the nitrogen atom of the indole ring by an alkyl, haloalkyl, |
---|
1055 | 1055 | | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, |
---|
1056 | 1056 | | halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2 -(4- |
---|
1057 | 1057 | | morpholinyl)ethyl, 1 -(N-methyl-2-pyrrolidinyl)methyl, 1 -(N-methyl-3- |
---|
1058 | 1058 | | |
---|
1059 | 1059 | | Req. No. 10084 Page 22 1 |
---|
1060 | 1060 | | 2 |
---|
1061 | 1061 | | 3 |
---|
1062 | 1062 | | 4 |
---|
1063 | 1063 | | 5 |
---|
1064 | 1064 | | 6 |
---|
1065 | 1065 | | 7 |
---|
1066 | 1066 | | 8 |
---|
1067 | 1067 | | 9 |
---|
1068 | 1068 | | 10 |
---|
1069 | 1069 | | 11 |
---|
1070 | 1070 | | 12 |
---|
1071 | 1071 | | 13 |
---|
1072 | 1072 | | 14 |
---|
1073 | 1073 | | 15 |
---|
1074 | 1074 | | 16 |
---|
1075 | 1075 | | 17 |
---|
1076 | 1076 | | 18 |
---|
1077 | 1077 | | 19 |
---|
1078 | 1078 | | 20 |
---|
1079 | 1079 | | 21 |
---|
1080 | 1080 | | 22 |
---|
1081 | 1081 | | 23 |
---|
1082 | 1082 | | 24 |
---|
1083 | 1083 | | |
---|
1084 | 1084 | | morpholinyl)methyl, (tetrahydropyran -4-yl)methyl, 1-methylazepanyl, |
---|
1085 | 1085 | | phenyl, or halophenyl group, whether or not further substituted on |
---|
1086 | 1086 | | the indole ring to any extent, and whether or not substituted on the |
---|
1087 | 1087 | | naphthyl ring to any extent. Naphthylmethyli ndoles include, but are |
---|
1088 | 1088 | | not limited to, (1-pentylindol-3-yl)(1-naphthyl)methane (JWH -175); |
---|
1089 | 1089 | | 3. Naphthoylpyrroles: any compound containing a 3 -(1- |
---|
1090 | 1090 | | naphthoyl)pyrrole structure with or without substitution at the |
---|
1091 | 1091 | | nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, |
---|
1092 | 1092 | | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, |
---|
1093 | 1093 | | halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2 -(4- |
---|
1094 | 1094 | | morpholinyl)ethyl, 1 -(N-methyl-2-pyrrolidinyl)methyl, 1 -(N-methyl-3- |
---|
1095 | 1095 | | morpholinyl)methyl, (tetrahydropyran -4-yl)methyl, 1-methylazepanyl, |
---|
1096 | 1096 | | phenyl, or halophenyl group, whether or not further substituted on |
---|
1097 | 1097 | | the pyrrole ring to any extent, and whether or not substituted on |
---|
1098 | 1098 | | the naphthyl group to any extent. Naphthoylpyrroles include, but |
---|
1099 | 1099 | | are not limited to: |
---|
1100 | 1100 | | a. 1-hexyl-2-phenyl-4-(1-naphthoyl)pyrrole (JWH-147), |
---|
1101 | 1101 | | b. 1-pentyl-5-(2-methylphenyl)-3-(1-naphthoyl)pyrrole |
---|
1102 | 1102 | | (JWH-370), |
---|
1103 | 1103 | | c. 1-pentyl-3-(1-naphthoyl)pyrrole (JWH -030), or |
---|
1104 | 1104 | | d. 1-hexyl-5-phenyl-3-(1-naphthoyl)pyrrole (JWH -147); |
---|
1105 | 1105 | | 4. Naphthylideneindenes: any compound containing a 1 -(1- |
---|
1106 | 1106 | | naphthylmethylene)indene structure with or without substitution at |
---|
1107 | 1107 | | the 3-position of the indene ring by an alkyl, haloalkyl, |
---|
1108 | 1108 | | |
---|
1109 | 1109 | | Req. No. 10084 Page 23 1 |
---|
1110 | 1110 | | 2 |
---|
1111 | 1111 | | 3 |
---|
1112 | 1112 | | 4 |
---|
1113 | 1113 | | 5 |
---|
1114 | 1114 | | 6 |
---|
1115 | 1115 | | 7 |
---|
1116 | 1116 | | 8 |
---|
1117 | 1117 | | 9 |
---|
1118 | 1118 | | 10 |
---|
1119 | 1119 | | 11 |
---|
1120 | 1120 | | 12 |
---|
1121 | 1121 | | 13 |
---|
1122 | 1122 | | 14 |
---|
1123 | 1123 | | 15 |
---|
1124 | 1124 | | 16 |
---|
1125 | 1125 | | 17 |
---|
1126 | 1126 | | 18 |
---|
1127 | 1127 | | 19 |
---|
1128 | 1128 | | 20 |
---|
1129 | 1129 | | 21 |
---|
1130 | 1130 | | 22 |
---|
1131 | 1131 | | 23 |
---|
1132 | 1132 | | 24 |
---|
1133 | 1133 | | |
---|
1134 | 1134 | | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, |
---|
1135 | 1135 | | halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2 -(4- |
---|
1136 | 1136 | | morpholinyl)ethyl, 1 -(N-methyl-2-pyrrolidinyl)methyl, 1 -(N-methyl-3- |
---|
1137 | 1137 | | morpholinyl)methyl, (tetrahydrop yran-4-yl)methyl, 1-methylazepanyl, |
---|
1138 | 1138 | | phenyl, or halophenyl group, whether or not further substituted on |
---|
1139 | 1139 | | the indene group to any extent, and whether or not substituted on |
---|
1140 | 1140 | | the naphthyl group to any extent. Naphthylmethylindenes include, |
---|
1141 | 1141 | | but are not limited to, (1 -[(3-pentyl)-1H-inden-1- |
---|
1142 | 1142 | | ylidene)methyl]naphthalene (JWH -176); |
---|
1143 | 1143 | | 5. Phenylacetylindoles: any compound containing a 3 - |
---|
1144 | 1144 | | phenylacetylindole structure with or without substitution at the |
---|
1145 | 1145 | | nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, |
---|
1146 | 1146 | | alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1 - |
---|
1147 | 1147 | | (N-methyl-2-piperidinyl)methyl, 2 -(4-morpholinyl)ethyl, 1 -(N-methyl- |
---|
1148 | 1148 | | 2-pyrrolidinyl)methyl, 1 -(N-methyl-3- morpholinyl)methyl, |
---|
1149 | 1149 | | (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or |
---|
1150 | 1150 | | halophenyl group, whether or not further substituted on the indole |
---|
1151 | 1151 | | ring to any extent, and whether or not substituted on the phenyl |
---|
1152 | 1152 | | ring to any extent. Phenylacetylindoles include, but a re not |
---|
1153 | 1153 | | limited to: |
---|
1154 | 1154 | | a. 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH -250), |
---|
1155 | 1155 | | b. 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole |
---|
1156 | 1156 | | (RCS-8), |
---|
1157 | 1157 | | c. 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH -203), |
---|
1158 | 1158 | | |
---|
1159 | 1159 | | Req. No. 10084 Page 24 1 |
---|
1160 | 1160 | | 2 |
---|
1161 | 1161 | | 3 |
---|
1162 | 1162 | | 4 |
---|
1163 | 1163 | | 5 |
---|
1164 | 1164 | | 6 |
---|
1165 | 1165 | | 7 |
---|
1166 | 1166 | | 8 |
---|
1167 | 1167 | | 9 |
---|
1168 | 1168 | | 10 |
---|
1169 | 1169 | | 11 |
---|
1170 | 1170 | | 12 |
---|
1171 | 1171 | | 13 |
---|
1172 | 1172 | | 14 |
---|
1173 | 1173 | | 15 |
---|
1174 | 1174 | | 16 |
---|
1175 | 1175 | | 17 |
---|
1176 | 1176 | | 18 |
---|
1177 | 1177 | | 19 |
---|
1178 | 1178 | | 20 |
---|
1179 | 1179 | | 21 |
---|
1180 | 1180 | | 22 |
---|
1181 | 1181 | | 23 |
---|
1182 | 1182 | | 24 |
---|
1183 | 1183 | | |
---|
1184 | 1184 | | d. 1-pentyl-3-(2-methylphenylacetyl)indole (JWH -251), |
---|
1185 | 1185 | | e. 1-pentyl-3-(4-methoxyphenylacetyl)indole (JWH -201), or |
---|
1186 | 1186 | | f. 1-pentyl-3-(3-methoxyphenylacetyl)indole (JWH -302); |
---|
1187 | 1187 | | 6. Cyclohexylphenols: any compound containing a 2 -(3- |
---|
1188 | 1188 | | hydroxycyclohexyl)phenol structure with or without substitution at |
---|
1189 | 1189 | | the 5-position of the phenoli c ring by an alkyl, haloalkyl, |
---|
1190 | 1190 | | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalk ylethyl, benzyl, |
---|
1191 | 1191 | | halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2 -(4- |
---|
1192 | 1192 | | morpholinyl)ethyl, 1 -(N-methyl-2-pyrrolidinyl)methyl, 1 -(N-methyl-3- |
---|
1193 | 1193 | | morpholinyl)methyl, (tetrahydropyran -4-yl)methyl, 1-methylazepanyl, |
---|
1194 | 1194 | | phenyl, or halophenyl group, and whether or not further substituted |
---|
1195 | 1195 | | on the cyclohexyl ring to any extent. Cyclohexylphenols include, |
---|
1196 | 1196 | | but are not limited to: |
---|
1197 | 1197 | | a. 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3- |
---|
1198 | 1198 | | hydroxycyclohexyl]-phenol (CP-47,497), |
---|
1199 | 1199 | | b. 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]- |
---|
1200 | 1200 | | phenol (cannabicyclohexanol; CP-47,497 C8 homologue), |
---|
1201 | 1201 | | or |
---|
1202 | 1202 | | c. 5-(1,1-dimethylheptyl)-2-[(1R,2R)-5-hydroxy-2-(3- |
---|
1203 | 1203 | | hydroxypropyl)cyclohexyl] -phenol (CP 55, 940); |
---|
1204 | 1204 | | 7. Benzoylindoles: any compound containing a 3-(benzoyl)indole |
---|
1205 | 1205 | | structure with or without substitution at the nitrogen atom of the |
---|
1206 | 1206 | | indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, |
---|
1207 | 1207 | | cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1 -(N-methyl- |
---|
1208 | 1208 | | |
---|
1209 | 1209 | | Req. No. 10084 Page 25 1 |
---|
1210 | 1210 | | 2 |
---|
1211 | 1211 | | 3 |
---|
1212 | 1212 | | 4 |
---|
1213 | 1213 | | 5 |
---|
1214 | 1214 | | 6 |
---|
1215 | 1215 | | 7 |
---|
1216 | 1216 | | 8 |
---|
1217 | 1217 | | 9 |
---|
1218 | 1218 | | 10 |
---|
1219 | 1219 | | 11 |
---|
1220 | 1220 | | 12 |
---|
1221 | 1221 | | 13 |
---|
1222 | 1222 | | 14 |
---|
1223 | 1223 | | 15 |
---|
1224 | 1224 | | 16 |
---|
1225 | 1225 | | 17 |
---|
1226 | 1226 | | 18 |
---|
1227 | 1227 | | 19 |
---|
1228 | 1228 | | 20 |
---|
1229 | 1229 | | 21 |
---|
1230 | 1230 | | 22 |
---|
1231 | 1231 | | 23 |
---|
1232 | 1232 | | 24 |
---|
1233 | 1233 | | |
---|
1234 | 1234 | | 2-piperidinyl)methyl, 2 -(4-morpholinyl)ethyl, 1-(N-methyl-2- |
---|
1235 | 1235 | | pyrrolidinyl)methyl, 1 -(N-methyl-3- morpholinyl)methyl, |
---|
1236 | 1236 | | (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or |
---|
1237 | 1237 | | halophenyl group, whether or not further substituted on the indole |
---|
1238 | 1238 | | ring to any extent, and whether or not substituted on the phenyl |
---|
1239 | 1239 | | group to any extent. Benzoylindoles include, but are not limited |
---|
1240 | 1240 | | to: |
---|
1241 | 1241 | | a. 1-pentyl-3-(4-methoxybenzoyl)indole (RCS -4), |
---|
1242 | 1242 | | b. 1-[2-(4-morpholinyl)ethyl]-2-methyl-3-(4- |
---|
1243 | 1243 | | methoxybenzoyl)indole (Pravadoline or WIN 48, 098), |
---|
1244 | 1244 | | c. 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM -694), |
---|
1245 | 1245 | | d. 1-pentyl-3-(2-iodobenzoyl)indole (AM -679), or |
---|
1246 | 1246 | | e. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2- |
---|
1247 | 1247 | | iodobenzoyl)indole (AM -2233); |
---|
1248 | 1248 | | 8. Cyclopropoylindoles: Any compound containing a 3 - |
---|
1249 | 1249 | | (cyclopropoyl)indole structure with substitution at the nitrogen |
---|
1250 | 1250 | | atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, |
---|
1251 | 1251 | | cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1 -(N-methyl- |
---|
1252 | 1252 | | 2-piperidinyl)methyl, 2 -(4-morpholinyl)ethyl, 1 -(N-methyl-2- |
---|
1253 | 1253 | | pyrrolidinyl)methyl, 1 -(N-methyl-3- morpholinyl)methyl, |
---|
1254 | 1254 | | (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or |
---|
1255 | 1255 | | halophenyl group, whether or not further substituted in the indole |
---|
1256 | 1256 | | ring to any extent and whether or not substituted in the |
---|
1257 | 1257 | | |
---|
1258 | 1258 | | Req. No. 10084 Page 26 1 |
---|
1259 | 1259 | | 2 |
---|
1260 | 1260 | | 3 |
---|
1261 | 1261 | | 4 |
---|
1262 | 1262 | | 5 |
---|
1263 | 1263 | | 6 |
---|
1264 | 1264 | | 7 |
---|
1265 | 1265 | | 8 |
---|
1266 | 1266 | | 9 |
---|
1267 | 1267 | | 10 |
---|
1268 | 1268 | | 11 |
---|
1269 | 1269 | | 12 |
---|
1270 | 1270 | | 13 |
---|
1271 | 1271 | | 14 |
---|
1272 | 1272 | | 15 |
---|
1273 | 1273 | | 16 |
---|
1274 | 1274 | | 17 |
---|
1275 | 1275 | | 18 |
---|
1276 | 1276 | | 19 |
---|
1277 | 1277 | | 20 |
---|
1278 | 1278 | | 21 |
---|
1279 | 1279 | | 22 |
---|
1280 | 1280 | | 23 |
---|
1281 | 1281 | | 24 |
---|
1282 | 1282 | | |
---|
1283 | 1283 | | cyclopropoyl ring to any extent. Cyclopropoylindoles include , but |
---|
1284 | 1284 | | are not limited to: |
---|
1285 | 1285 | | a. 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole |
---|
1286 | 1286 | | (UR-144), |
---|
1287 | 1287 | | b. 1-(5-chloropentyl)-3-(2,2,3,3- |
---|
1288 | 1288 | | tetramethylcyclopropoyl)indole (5Cl -UR-144), or |
---|
1289 | 1289 | | c. 1-(5-fluoropentyl)-3-(2,2,3,3- |
---|
1290 | 1290 | | tetramethylcyclopropoyl)indole (XLR11); |
---|
1291 | 1291 | | 9. Indole Amides: Any compound containing a 1H -Indole-3- |
---|
1292 | 1292 | | carboxamide structure with or wi thout substitution at the nitrogen |
---|
1293 | 1293 | | atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, |
---|
1294 | 1294 | | cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1 -(N-methyl- |
---|
1295 | 1295 | | 2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1 -(N-methyl-2- |
---|
1296 | 1296 | | pyrrolidinyl)methyl, 1 -(N-methyl-3- morpholinyl)methyl, |
---|
1297 | 1297 | | (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or |
---|
1298 | 1298 | | halophenyl group, whether or not substituted at the carboxamide |
---|
1299 | 1299 | | group by an adamantyl, n aphthyl, phenyl, benzyl, quinolinyl, |
---|
1300 | 1300 | | cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl- |
---|
1301 | 1301 | | 1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3- |
---|
1302 | 1302 | | dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not |
---|
1303 | 1303 | | further substituted in the indole, adamantyl, naphthyl, phenyl, |
---|
1304 | 1304 | | pyrrole, quninolinyl, or cycloalkyl rings to any extent. Indole |
---|
1305 | 1305 | | Amides include, but are not limited to: |
---|
1306 | 1306 | | |
---|
1307 | 1307 | | Req. No. 10084 Page 27 1 |
---|
1308 | 1308 | | 2 |
---|
1309 | 1309 | | 3 |
---|
1310 | 1310 | | 4 |
---|
1311 | 1311 | | 5 |
---|
1312 | 1312 | | 6 |
---|
1313 | 1313 | | 7 |
---|
1314 | 1314 | | 8 |
---|
1315 | 1315 | | 9 |
---|
1316 | 1316 | | 10 |
---|
1317 | 1317 | | 11 |
---|
1318 | 1318 | | 12 |
---|
1319 | 1319 | | 13 |
---|
1320 | 1320 | | 14 |
---|
1321 | 1321 | | 15 |
---|
1322 | 1322 | | 16 |
---|
1323 | 1323 | | 17 |
---|
1324 | 1324 | | 18 |
---|
1325 | 1325 | | 19 |
---|
1326 | 1326 | | 20 |
---|
1327 | 1327 | | 21 |
---|
1328 | 1328 | | 22 |
---|
1329 | 1329 | | 23 |
---|
1330 | 1330 | | 24 |
---|
1331 | 1331 | | |
---|
1332 | 1332 | | a. N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide |
---|
1333 | 1333 | | (2NE1), |
---|
1334 | 1334 | | b. N-(1-adamantyl)-1-(5-fluoropentyl-1H-indole-3- |
---|
1335 | 1335 | | carboxamide (STS-135), |
---|
1336 | 1336 | | c. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H- |
---|
1337 | 1337 | | indole-3-carboxamide (ADBICA), |
---|
1338 | 1338 | | d. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5- |
---|
1339 | 1339 | | fluoropentyl)-1H-indole-3-carboxamide (5F-ADBICA), |
---|
1340 | 1340 | | e. N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide |
---|
1341 | 1341 | | (NNE1), |
---|
1342 | 1342 | | f. 1-(5-fluoropentyl)-N-(naphthalene-1-yl)-1H-indole-3- |
---|
1343 | 1343 | | carboxamide (5F-NNE1), |
---|
1344 | 1344 | | g. N-benzyl-1-pentyl-1H-indole-3-carboxamide (SDB-006), |
---|
1345 | 1345 | | or |
---|
1346 | 1346 | | h. N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide |
---|
1347 | 1347 | | (5F-SDB-006); |
---|
1348 | 1348 | | 10. Indole Esters: Any compound containing a 1H-Indole-3- |
---|
1349 | 1349 | | carboxylate structure with or without substitution a t the nitrogen |
---|
1350 | 1350 | | atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, |
---|
1351 | 1351 | | cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1 -(N-methyl- |
---|
1352 | 1352 | | 2-piperidinyl)methyl, 2 -(4-morpholinyl)ethyl, 1 -(N-methyl-2- |
---|
1353 | 1353 | | pyrrolidinyl)methyl, 1 -(N-methyl-3-morpholinyl)methyl, |
---|
1354 | 1354 | | (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or |
---|
1355 | 1355 | | halophenyl group, whether or not substituted at the carboxylate |
---|
1356 | 1356 | | |
---|
1357 | 1357 | | Req. No. 10084 Page 28 1 |
---|
1358 | 1358 | | 2 |
---|
1359 | 1359 | | 3 |
---|
1360 | 1360 | | 4 |
---|
1361 | 1361 | | 5 |
---|
1362 | 1362 | | 6 |
---|
1363 | 1363 | | 7 |
---|
1364 | 1364 | | 8 |
---|
1365 | 1365 | | 9 |
---|
1366 | 1366 | | 10 |
---|
1367 | 1367 | | 11 |
---|
1368 | 1368 | | 12 |
---|
1369 | 1369 | | 13 |
---|
1370 | 1370 | | 14 |
---|
1371 | 1371 | | 15 |
---|
1372 | 1372 | | 16 |
---|
1373 | 1373 | | 17 |
---|
1374 | 1374 | | 18 |
---|
1375 | 1375 | | 19 |
---|
1376 | 1376 | | 20 |
---|
1377 | 1377 | | 21 |
---|
1378 | 1378 | | 22 |
---|
1379 | 1379 | | 23 |
---|
1380 | 1380 | | 24 |
---|
1381 | 1381 | | |
---|
1382 | 1382 | | group by an adamantyl, naphthyl, phenyl, benz yl, quinolinyl, |
---|
1383 | 1383 | | cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl- |
---|
1384 | 1384 | | 1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3- |
---|
1385 | 1385 | | dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not |
---|
1386 | 1386 | | further substituted in the indole, adamantyl , naphthyl, phenyl, |
---|
1387 | 1387 | | pyrrole, quinolinyl, or cycloalkyl rings to any extent. Indole |
---|
1388 | 1388 | | Esters include, but are not limited to: |
---|
1389 | 1389 | | a. quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB- |
---|
1390 | 1390 | | 22), |
---|
1391 | 1391 | | b. quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3- |
---|
1392 | 1392 | | carboxylate (5F-PB-22), |
---|
1393 | 1393 | | c. quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3- |
---|
1394 | 1394 | | carboxylate (BB-22), |
---|
1395 | 1395 | | d. naphthalen-1-yl 1-(4-fluorobenzyl)-1H-indole-3- |
---|
1396 | 1396 | | carboxylate (FDU-PB-22), or |
---|
1397 | 1397 | | e. naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3- |
---|
1398 | 1398 | | carboxylate (NM2201); |
---|
1399 | 1399 | | 11. Adamantanoylindoles: Any compo und containing an |
---|
1400 | 1400 | | adamantanyl-(1H-indol-3-yl)methanone structure with or without |
---|
1401 | 1401 | | substitution at the nitrogen atom of the indole ring by an alkyl, |
---|
1402 | 1402 | | haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, |
---|
1403 | 1403 | | benzyl, halobenzyl, 1 -(N-methyl-2-piperidinyl)methyl, 2-(4- |
---|
1404 | 1404 | | morpholinyl)ethyl, 1 -(N-methyl-2-pyrrolidinyl)methyl, 1 -(N-methyl-3- |
---|
1405 | 1405 | | morpholinyl)methyl, (tetrahydropyran -4-yl)methyl, 1-methylazepanyl, |
---|
1406 | 1406 | | |
---|
1407 | 1407 | | Req. No. 10084 Page 29 1 |
---|
1408 | 1408 | | 2 |
---|
1409 | 1409 | | 3 |
---|
1410 | 1410 | | 4 |
---|
1411 | 1411 | | 5 |
---|
1412 | 1412 | | 6 |
---|
1413 | 1413 | | 7 |
---|
1414 | 1414 | | 8 |
---|
1415 | 1415 | | 9 |
---|
1416 | 1416 | | 10 |
---|
1417 | 1417 | | 11 |
---|
1418 | 1418 | | 12 |
---|
1419 | 1419 | | 13 |
---|
1420 | 1420 | | 14 |
---|
1421 | 1421 | | 15 |
---|
1422 | 1422 | | 16 |
---|
1423 | 1423 | | 17 |
---|
1424 | 1424 | | 18 |
---|
1425 | 1425 | | 19 |
---|
1426 | 1426 | | 20 |
---|
1427 | 1427 | | 21 |
---|
1428 | 1428 | | 22 |
---|
1429 | 1429 | | 23 |
---|
1430 | 1430 | | 24 |
---|
1431 | 1431 | | |
---|
1432 | 1432 | | phenyl, or halophenyl group, whether or not further substituted in |
---|
1433 | 1433 | | the indole ring to any extent and w hether or not substituted in the |
---|
1434 | 1434 | | adamantyl ring to any extent. Adamantanoylindoles include, but are |
---|
1435 | 1435 | | not limited to: |
---|
1436 | 1436 | | a. adamantan-1-yl[1-[(1-methyl-2-piperidinyl)methyl]-1H- |
---|
1437 | 1437 | | indol-3-yl]methanone (AM1248), or |
---|
1438 | 1438 | | b. adamantan-1-yl-(1-pentyl-1H-indol-3-yl)methanone (AB- |
---|
1439 | 1439 | | 001); |
---|
1440 | 1440 | | 12. Carbazole Ketone: Any compound containing (9H -carbazole-3- |
---|
1441 | 1441 | | yl) methanone structure with or without substitution at the nitrogen |
---|
1442 | 1442 | | atom of the carbazole ring by an alkyl, haloalkyl, cyanoalkyl, |
---|
1443 | 1443 | | alkenyl, cycloalkylmethyl, cycloalkylethyl, ben zyl, halobenzyl, 1- |
---|
1444 | 1444 | | (N-methyl-2-piperidinyl)methyl, 2 -(4-morpholinyl)ethyl, 1 -(N-methyl- |
---|
1445 | 1445 | | 2-pyrrolidinyl)methyl, 1 -(N-methyl-3-morpholinyl)methyl, |
---|
1446 | 1446 | | (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or |
---|
1447 | 1447 | | halophenyl group, with substitution at the carbon of the methanone |
---|
1448 | 1448 | | group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl, |
---|
1449 | 1449 | | cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl- |
---|
1450 | 1450 | | 1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3- |
---|
1451 | 1451 | | dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not |
---|
1452 | 1452 | | further substituted at the carbazole, adamantyl, naphthyl, phenyl, |
---|
1453 | 1453 | | pyrrole, quinolinyl, or cycloalkyl rings to any extent. Carbazole |
---|
1454 | 1454 | | Ketones include, but are not limited to, naphthalen -1-yl(9-pentyl- |
---|
1455 | 1455 | | 9H-carbazol-3-yl)methanone (EG-018); |
---|
1456 | 1456 | | |
---|
1457 | 1457 | | Req. No. 10084 Page 30 1 |
---|
1458 | 1458 | | 2 |
---|
1459 | 1459 | | 3 |
---|
1460 | 1460 | | 4 |
---|
1461 | 1461 | | 5 |
---|
1462 | 1462 | | 6 |
---|
1463 | 1463 | | 7 |
---|
1464 | 1464 | | 8 |
---|
1465 | 1465 | | 9 |
---|
1466 | 1466 | | 10 |
---|
1467 | 1467 | | 11 |
---|
1468 | 1468 | | 12 |
---|
1469 | 1469 | | 13 |
---|
1470 | 1470 | | 14 |
---|
1471 | 1471 | | 15 |
---|
1472 | 1472 | | 16 |
---|
1473 | 1473 | | 17 |
---|
1474 | 1474 | | 18 |
---|
1475 | 1475 | | 19 |
---|
1476 | 1476 | | 20 |
---|
1477 | 1477 | | 21 |
---|
1478 | 1478 | | 22 |
---|
1479 | 1479 | | 23 |
---|
1480 | 1480 | | 24 |
---|
1481 | 1481 | | |
---|
1482 | 1482 | | 13. Benzimidazole Ketone: Any compound containing |
---|
1483 | 1483 | | (benzimidazole-2-yl) methanone structure with or without |
---|
1484 | 1484 | | substitution at either nitrogen atom of the benzimidazole ring by an |
---|
1485 | 1485 | | alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, |
---|
1486 | 1486 | | cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2- |
---|
1487 | 1487 | | piperidinyl)methyl, 2 -(4-morpholinyl)ethyl, 1 -(N-methyl-2- |
---|
1488 | 1488 | | pyrrolidinyl)methyl, 1 -(N-methyl-3-morpholinyl)methyl, |
---|
1489 | 1489 | | (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or |
---|
1490 | 1490 | | halophenyl group, with substitution at the carbon of the m ethanone |
---|
1491 | 1491 | | group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl, |
---|
1492 | 1492 | | cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl- |
---|
1493 | 1493 | | 1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3- |
---|
1494 | 1494 | | dimethyl-1-oxobutan-2-yl or pyrrole group, and wheth er or not |
---|
1495 | 1495 | | further substituted in the benzimidazole, adamantyl, naphthyl, |
---|
1496 | 1496 | | phenyl, pyrrole, quinolinyl, or cycloalkyl rings to any extent. |
---|
1497 | 1497 | | Benzimidazole Ketones include, but are not limited to: |
---|
1498 | 1498 | | a. naphthalen-1-yl(1-pentyl-1H-benzo[d]imidazol-2- |
---|
1499 | 1499 | | l)methanone (JWH-018 benzimidazole analog), or |
---|
1500 | 1500 | | b. (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2- |
---|
1501 | 1501 | | yl)(naphthalen-1-yl)methanone (FUBIMINA); and |
---|
1502 | 1502 | | 14. Modified by Replacement: any compound defined in this |
---|
1503 | 1503 | | subsection that is modified by replacement of a carbon with nitrogen |
---|
1504 | 1504 | | in the indole, naphthyl, indene, benzimidazole, or carbazole ring. |
---|
1505 | 1505 | | |
---|
1506 | 1506 | | Req. No. 10084 Page 31 1 |
---|
1507 | 1507 | | 2 |
---|
1508 | 1508 | | 3 |
---|
1509 | 1509 | | 4 |
---|
1510 | 1510 | | 5 |
---|
1511 | 1511 | | 6 |
---|
1512 | 1512 | | 7 |
---|
1513 | 1513 | | 8 |
---|
1514 | 1514 | | 9 |
---|
1515 | 1515 | | 10 |
---|
1516 | 1516 | | 11 |
---|
1517 | 1517 | | 12 |
---|
1518 | 1518 | | 13 |
---|
1519 | 1519 | | 14 |
---|
1520 | 1520 | | 15 |
---|
1521 | 1521 | | 16 |
---|
1522 | 1522 | | 17 |
---|
1523 | 1523 | | 18 |
---|
1524 | 1524 | | 19 |
---|
1525 | 1525 | | 20 |
---|
1526 | 1526 | | 21 |
---|
1527 | 1527 | | 22 |
---|
1528 | 1528 | | 23 |
---|
1529 | 1529 | | 24 |
---|
1530 | 1530 | | |
---|
1531 | 1531 | | H. Any prescription drug approved by the federal Food and Drug |
---|
1532 | 1532 | | Administration under the provisions of Section 505 of the Federal |
---|
1533 | 1533 | | Food, Drug and Cosmetic Act, Title 21 of the United States Co de, |
---|
1534 | 1534 | | Section 355, that is designated, rescheduled or deleted as a |
---|
1535 | 1535 | | controlled substance under federal law by the United States Drug |
---|
1536 | 1536 | | Enforcement Administration shall be excluded from Schedule I and |
---|
1537 | 1537 | | shall be prescribed, distributed, dispensed or used in accord ance |
---|
1538 | 1538 | | with federal law upon the issuance of a notice, final rule or |
---|
1539 | 1539 | | interim final rule by the United States Drug Enforcement |
---|
1540 | 1540 | | Administration designating, rescheduling or deleting as a controlled |
---|
1541 | 1541 | | substance such a drug product under federal law, unless and unt il |
---|
1542 | 1542 | | the State Board of Pharmacy takes action pursuant to Section 2 -201 |
---|
1543 | 1543 | | of this title. If the Board of Pharmacy does not take action |
---|
1544 | 1544 | | pursuant to Section 2 -201 of this title, the drug product shall be |
---|
1545 | 1545 | | deemed to be designated, rescheduled or deleted as a cont rolled |
---|
1546 | 1546 | | substance in accordance with federal law and in compliance with the |
---|
1547 | 1547 | | Uniform Controlled Dangerous Substances Act. |
---|
1548 | 1548 | | SECTION 2. This act shall become effective November 1, 2025. |
---|
1549 | 1549 | | |
---|
1550 | 1550 | | 60-1-10084 GRS 12/31/24 |
---|